.webp){kind=small}
For many SpaceX employees, incentive stock options (ISOs) represent one of the largest components of their potential wealth - sometimes larger than everything else they own combined. And now that SpaceX trades publicly, decisions that were once theoretical have become urgent and real.
But exercising ISOs isn't simply a question of whether SpaceX stock will go up. A thoughtful exercise decision has to weigh the cash required to exercise, the current value of the stock, potential Alternative Minimum Tax (AMT) exposure, ISO holding-period rules, your liquidity needs, your concentration risk, and how lockups and trading windows affect when you can actually sell.
At Axon Capital Management, we help SpaceX employees navigate equity compensation and build wealth plans around it - ISOs, RSUs, and the concentrated stock positions that result from years of accumulating both.
Here's the core idea this guide is built around: the biggest mistake SpaceX employees can make with ISOs is treating the exercise decision as a simple stock-market bet. The right strategy depends on taxes, liquidity, risk tolerance, and your broader financial plan - not just your view on the stock.
A stock option is the right, but not the obligation, to buy company shares at a fixed price. Five terms define every option grant. The grant date is when the company awards you the options. The exercise price (or strike price) is the fixed price at which you can buy shares, typically set at the stock's fair market value on the grant date. Vesting is the schedule over which you earn the right to exercise, commonly over four years. Expiration is the deadline after which unexercised options are forfeited - usually ten years from grant, and often much sooner if you leave the company. Exercise is the act of actually buying the shares at your strike price.
The value of an option comes from the gap between your strike price and what the stock is worth. An employee granted options at a $25 strike when SpaceX shares now trade well above $100 is holding significant embedded value - but that value isn't realized, and isn't taxed, until specific events occur.
Before making any decisions, gather the facts of your specific grants. In your equity administration portal (or your grant agreements), you can find the number of options in each grant, the exercise price for each, your vesting schedule and how many options are currently vested, each grant's expiration date, and the original grant date - which matters because the two-year ISO holding period runs from that date. If you have multiple grants from different years, treat each one separately: they'll have different strike prices, different holding-period clocks, and potentially very different economics.
When you exercise, three numbers matter. The exercise price is what you pay per share. The fair market value (FMV) is what the shares are worth at exercise - now that SpaceX is public, that's simply the market price. The difference between them is the bargain element, sometimes called the spread.
For regular income tax purposes, exercising an ISO is generally not a taxable event. You don't owe ordinary income tax on the spread the way you would with NSOs. That's the good news. The complication is that the spread doesn't disappear from the tax picture—it moves into the AMT calculation.
A simple example. Suppose an employee holds 10,000 ISOs with a $20 exercise price, and SpaceX stock is worth $100 per share at exercise:
That $800,000 generally isn't regular taxable income in the year of exercise. But it is an adjustment that gets added to income for Alternative Minimum Tax purposes - and for a spread that large, AMT is not a footnote. It can be a six-figure tax bill on shares you haven't sold.
If there's one section of this guide to read twice, it's this one. AMT is where well-intentioned ISO exercises go wrong.
The Alternative Minimum Tax is a parallel tax system that runs alongside the regular income tax. Each year, your tax is effectively calculated both ways - regular tax and tentative minimum tax - and you pay the higher of the two. Most people never notice the AMT because their regular tax is higher. But the ISO bargain element is one of the classic triggers: it's excluded from regular taxable income but included in AMT income. Exercise enough ISOs with a large enough spread, and your AMT calculation can leap past your regular tax, leaving you with a significant additional bill.
At a high level: your AMT income starts with your regular taxable income, adds back certain items - including the ISO bargain element - subtracts an AMT exemption amount (which phases out at higher income levels), and applies AMT rates of 26% or 28%. If the resulting tentative minimum tax exceeds your regular tax, you owe the difference as AMT.
Two practical implications follow. First, the AMT cost of an exercise depends not just on the spread but on your entire tax picture that year—income, deductions, filing status, and where you sit relative to the exemption phaseout. Second, because the exemption and phaseout thresholds are adjusted by legislation and inflation, the same exercise can produce different AMT results in different years. (Exemption amounts and phaseout thresholds have changed under recent tax legislation—verify current-year figures with your CPA before modeling any exercise.)
The only reliable way to estimate AMT is to run a projection of your full tax return with the proposed exercise included - not to apply a rule of thumb to the spread. That said, a rough planning shortcut is to multiply the bargain element by 26–28% to get a ceiling on the incremental AMT an exercise might create, then refine from there. Many employees are surprised to learn there's often an amount of ISOs they can exercise each year without triggering AMT at all - the gap between their regular tax and their tentative minimum tax creates room. Finding that break-even amount is one of the most valuable planning exercises available, and it's a core part of the modeling we do with clients and their CPAs.
This is the risk scenario every ISO holder needs to understand, because it's exactly what recent volatility has made real. You could exercise ISOs, incur AMT based on the spread at exercise, and then watch the stock decline before you sell.
The tax is based on the bargain element on the day you exercised—not on what the stock is worth later. An employee who exercised when SpaceX traded near its post-IPO peak of roughly $225 in June 2026 owes AMT calculated on that spread, even though the stock has since fallen sharply. In severe cases, employees can owe more in AMT than the shares are ultimately worth. This exact dynamic devastated employees at many companies during the dot-com bust, and it's why "exercise and hold" should never be done casually or at maximum size. There is a partial escape hatch—selling in the same calendar year as the exercise (a disqualifying disposition, covered below) generally removes the AMT adjustment for that exercise, which can serve as a rip cord if the stock is falling. But that trade-off has its own consequences and deadlines, which is why exercises should be monitored, not set and forgotten.
Often, yes—partially or fully, over time. AMT paid because of ISO exercises generates a Minimum Tax Credit (MTC) that carries forward and can offset your regular tax in future years, in years when your regular tax exceeds your tentative minimum tax. In practice, recovering the credit can take years, and the timing depends on your income pattern—another reason ISO planning is inherently multi-year. Think of ISO-related AMT less as a pure cost and more as an interest-free loan to the government with an uncertain repayment schedule: real money out the door now, potentially recovered later.
ISO planning sits at the intersection of tax and investment decisions, which is why it works best as a team effort. At Axon Capital Management, our role is to model exercise scenarios across multiple years, estimate the potential tax consequences of each, coordinate directly with your CPA so the tax projections reflect your actual return, and build the liquidity strategy—where the cash to exercise and pay taxes comes from, and when shares get sold. Your CPA brings precision on the tax return itself; we bring the investment, risk, and cash-flow framework around it. Neither alone sees the whole picture.
There's no universally right time - but there are frameworks for thinking about it.
Exercising early starts your holding-period clocks sooner and can lock in a smaller spread (and therefore smaller AMT exposure) if the stock keeps rising. The cost is that your capital is committed earlier, the stock could fall after you exercise, and you give up optionality—an unexercised option can't lose more than nothing, while exercised shares can. Waiting preserves flexibility and keeps your cash free, but a rising stock means a growing spread, growing AMT exposure, and a bigger check to write later. Waiting too long also runs into the hard wall of expiration dates and the softer wall of post-termination exercise windows if you ever leave.
For years, SpaceX employees faced this decision without a public market—and many employees at other private companies still do. Exercising private-company ISOs means committing real cash for shares you may not be able to sell for years, based on a private valuation (typically a 409A valuation) rather than a market price, while taking on AMT exposure with no liquidity to pay for it and bearing the full risk of a decline before any liquidity event arrives. Employees who exercised SpaceX ISOs early at low strike prices and modest spreads—accepting those risks—are the ones now positioned for potential qualifying dispositions at long-term capital gains rates. Employees who exercised large blocks late, at high private valuations, took on much larger AMT exposure for a shorter head start. Both groups made a real risk decision, not just a tax decision.
In the run-up to a public listing, many employees consider exercising so that their one-year post-exercise holding period starts before—or at—the IPO. The logic: if you exercise before the IPO, your holding-period clock is already running while you're locked up anyway, potentially allowing you to sell for long-term capital gains treatment soon after lockup expiration. The risk: you're exercising based on pre-IPO valuations, committing cash and incurring potential AMT before you know how the stock will trade. As SpaceX's own post-IPO decline shows, IPO pricing is not a floor.
Now that SpaceX is public, the decision changes in several important ways. You have real liquidity—shares acquired by exercise can actually be sold (subject to lockups and trading windows). The valuation is transparent: the spread is based on the market price, not a 409A estimate. You can execute a same-day exercise-and-sell, which eliminates the "cash trapped in private stock" problem entirely. And tax planning becomes more precise, because you can size exercises against a known price and sell shares to fund the AMT if needed. The trade-off is that public prices move daily—sometimes violently, as SpaceX shareholders have seen since June—so timing risk is visible in a way it never was privately.
The favorable tax treatment of ISOs is conditional. Two clocks must both run out.
To receive full ISO tax treatment, you generally must not sell the shares until at least two years after the grant date of the options. For long-tenured SpaceX employees, older grants have often already satisfied this test; recent grants may not have.
You also generally must hold the shares at least one year after the exercise date. This clock doesn't start until you actually exercise—holding vested but unexercised options for years does nothing for this test.
If you satisfy both holding periods, selling the shares is a qualifying disposition: your entire gain from exercise price to sale price is taxed as long-term capital gain. For an employee with a $25 strike selling at $150, that's the difference between long-term capital gains rates and ordinary income rates applied to a $125-per-share gain—a potentially enormous tax saving, partially offset by any AMT paid along the way (some of which may return via the Minimum Tax Credit).
Selling before both holding periods are met is a disqualifying disposition. The bargain element at exercise (or your actual gain, if smaller and the sale occurs in the same year) is taxed as ordinary income, and any additional appreciation after exercise is capital gain. One important nuance: if you exercise and sell within the same calendar year, the ISO AMT adjustment for that exercise generally goes away—you pay ordinary income tax on the spread instead. That's why same-year exercise-and-sell is the standard tool for diversifying without stacking AMT on top.
No—and this point deserves emphasis. The qualifying-disposition tax benefit is real, but chasing it means holding a concentrated, volatile position for at least a year after exercise. An employee who exercised at $150 and held for tax reasons while the stock fell toward $115 "saved" taxes on a gain that partially evaporated. Tax optimization should never automatically override risk management. The right question isn't "How do I pay the least tax?" It's "What's the best after-tax outcome I can achieve at a level of risk I can actually afford?" Sometimes that answer is a disqualifying disposition, taxes paid, and a diversified portfolio.
There are four broad strategies, and most real plans combine several.
Exercise, pay any AMT, hold at least one year (and two from grant), and sell as a qualifying disposition. This maximizes the potential tax benefit and is best suited for employees with high conviction in the stock, high risk tolerance, and significant outside liquidity—enough to fund the exercise cost and the AMT without stress, and to absorb a major decline without endangering their plan.
Exercise and sell immediately (or within the same calendar year). This is typically a disqualifying disposition—the spread is taxed as ordinary income—but it generally avoids the ISO AMT adjustment, requires little or no cash outlay when done as a same-day sale, and converts concentrated option value into diversifiable proceeds. It's the workhorse strategy for reducing concentration risk, and it's often the right choice for the portion of your options you shouldn't be risking.
Spread exercises across multiple tax years. This manages AMT by keeping each year's bargain element small enough to stay under—or only modestly over—your AMT break-even, reduces the risk of exercising everything at a single bad price, and creates a repeatable annual process instead of one giant decision. Multi-year modeling is essential here, and it's where advisor–CPA coordination pays for itself.
A discipline more than a strategy: never commit exercise cash (plus projected AMT) that you'd need back if the shares became worthless or untradeable. This was the cardinal rule for private-company exercises, and it still applies post-IPO—lockups, blackout windows, and sharp drawdowns can all separate you from your money longer than expected.
A simple framework captures the moving parts:
Exercise Cost + Potential AMT + Liquidity Needs + Concentration Risk vs. Expected Upside
If the left side of that equation strains your finances—if funding the exercise and the tax would crowd out your cash reserves, or if the position would push your SpaceX concentration past what your plan can tolerate—the expected upside on the right side has to be extraordinary to justify it. For most employees, the answer wasn't all-or-nothing: it was exercising a sized portion that fit the framework, and leaving the rest for after the IPO when liquidity and price transparency improved.
A common misconception: the IPO did not convert anyone's options into stock. Options remain options until you exercise them—paying the strike price and, where applicable, planning for AMT. Vesting schedules, expiration dates, and post-termination exercise windows all continue to apply exactly as before. If you hold unexercised ISOs today, you still have decisions to make.
Public trading transforms the planning landscape in four ways. Liquidity: exercised shares can actually be sold, which makes exercise-and-sell and gradual diversification executable for the first time. Market price: the spread—and therefore AMT exposure—is now based on a transparent, real-time price instead of a periodic 409A valuation. Ability to sell: you can fund exercise costs and tax bills from the position itself via same-day sales. Diversification: the biggest practical change of all—reducing concentration is no longer hostage to tender offers and secondary markets.
Public doesn't mean unrestricted. SpaceX employees may still face IPO lockup provisions restricting sales for a period after the June 2026 listing, company-imposed trading windows that only open after earnings releases, blackout periods around material events, and insider-trading policies. For employees who expect to sell systematically over time, a 10b5-1 plan—a predetermined written trading plan—can allow sales to continue even during closed windows and removes the temptation to time each sale. Check your specific lockup terms and the company's insider trading policy before building any plan around assumed sale dates.
SpaceX's first weeks as a public company are a live case study in why price path matters. The stock priced at $135, closed its first day around $161, touched roughly $225 intraday on June 16, and has since traded down into the range of roughly $115–$130—below the IPO price. (Update these figures immediately before publication.) An ISO holder's outcome depends on the price at four separate moments: at exercise (sets the spread and AMT), at the IPO (sets the initial public mark), at lockup expiration (the first real chance for many to sell), and at sale (determines the actual gain). Those four prices can differ dramatically—employees who exercised near the peak face AMT on a spread that no longer exists. Planning that considers only one of those moments is incomplete.
Many SpaceX employees hold both ISOs and RSUs, and they behave very differently:
Neither is simply "better." RSUs deliver value with certainty—shares arrive at vesting, taxed as ordinary income, no cash outlay, no AMT. ISOs offer a larger potential prize—full-spread capital gains treatment—in exchange for cash commitment, AMT exposure, and holding-period risk. Companies often grant ISOs earlier in their life (when strike prices are low and the upside case dominates) and shift toward RSUs as the valuation matures, which is why long-tenured employees frequently hold low-strike ISOs alongside newer RSU grants. The two also interact in planning: RSU vesting raises your ordinary income, which changes your AMT break-even for ISO exercises in the same year. They should be planned together, not in separate silos.
Consider a hypothetical employee, an engineer with:
Assume the grants are more than two years old, so the two-year test is already satisfied. Here's how three paths compare. (All figures are simplified illustrations—actual taxes depend on the employee's full return.)
Scenario A: Exercise and Hold. The employee pays $500,000 to exercise and holds for a qualifying disposition. The $2.5M bargain element flows into the AMT calculation; at a 26–28% AMT rate, the incremental tax could plausibly be in the neighborhood of $600,000–$700,000, due the following April—on shares that haven't been sold. Total cash committed: roughly $1.1–1.2M. If the stock holds or rises and the shares are sold after one year, the entire gain is long-term capital gain, and much of the AMT may come back over time via the Minimum Tax Credit. But the concentration risk is maximal: if SpaceX falls from $150 to $100 during the holding year, the position loses $1M of value while the AMT bill on the vanished spread still stands. This scenario suits an employee with several million dollars of outside liquidity and genuine capacity for loss—not one whose net worth is mostly this position.
Scenario B: Exercise and Sell (same day). The employee executes a cashless exercise-and-sale at $150. This is a disqualifying disposition: the $2.5M spread is taxed as ordinary income (roughly $900,000–$1M+ combined federal/state for a high earner, varying by state), but the same-year sale generally eliminates the ISO AMT adjustment. No exercise cash is required—costs and taxes come out of proceeds. The employee walks away with roughly $1.5–1.6M after tax, fully diversifiable, with zero remaining exposure to a SpaceX decline on these shares. The tax bill is the highest of the three scenarios, but so is the certainty.
Scenario C: Exercise 5,000 Options Per Year. The employee exercises in four annual tranches. Each year's exercise costs $125,000 and creates a bargain element of roughly $625,000 (at a constant $150 price—reality will vary). The smaller annual spread may keep AMT modest or even near zero depending on the employee's other income and where their AMT break-even sits, each tranche starts its own one-year clock toward qualifying treatment, and no single exercise is hostage to one day's price. The trade-offs: the strategy takes four years to complete, later tranches carry price risk in both directions, and the employee remains partially concentrated throughout. For many employees, a version of this—sized tranches, sometimes paired with same-year sales of a portion—is the most livable balance of tax efficiency and risk control.
The most expensive surprise in equity compensation. Employees exercise in December, celebrate, and discover the following spring that they owe hundreds of thousands in AMT they never modeled. Always project the full tax impact before exercising, not after.
Exercise cash plus AMT is money at risk. If losing it would derail your plan, the exercise was oversized—regardless of how the stock performs.
Expiration dates are absolute, and post-termination windows (often 90 days) are short. Employees who wait until a deadline forfeit all flexibility on timing, tax years, and price—and sometimes forfeit the options themselves.
Holding for qualifying treatment while a concentrated position collapses is the classic case of winning the tax battle and losing the wealth war. After-tax outcomes, at acceptable risk, are the goal.
Different grants expire on different dates. A ten-year clock feels infinite until year nine. Inventory every grant's expiration now and build the plan backward from the earliest one.
SpaceX's IPO created enormous paper wealth—and then the stock fell below its offering price within six weeks. An IPO is a liquidity event, not a guarantee. Plans built on "the stock only goes up" aren't plans.
Between salary, unvested grants, RSUs, and ISO shares, employees often carry far more SpaceX exposure than they realize. Add it all up—including unexercised option value—before deciding whether to add more.
ISO planning done without your actual tax return is guesswork. The advisor models strategy; the CPA grounds it in your real numbers. Skipping either half produces errors in the six figures.
At Axon Capital Management, we help SpaceX employees navigate complex equity compensation decisions, including incentive stock options, RSUs, and concentrated stock positions. Our work spans four areas.
We model exercise scenarios across your specific grants—strike prices, vesting, expirations—evaluate timing against prices, tax years, and trading windows, and compare strategies (hold, sell, gradual, blended) in after-tax, risk-adjusted terms.
We estimate your AMT exposure for any proposed exercise, identify your annual AMT break-even amount, model multi-year exercise programs that manage the credit recovery, and coordinate directly with your tax professionals so projections match your actual return.
We help you determine appropriate total SpaceX exposure across every form you hold it—shares, RSUs, vested and unvested options—then build diversification strategies and manage the liquidity to fund exercises, taxes, and your life along the way.
We design exercise strategies around liquidity events, selling strategies for after them, 10b5-1 plans for systematic diversification through trading windows, and lockup planning so you're ready to act—not deciding under pressure—when restrictions lift.
SpaceX ISOs are incentive stock options—rights granted to employees to purchase SpaceX shares at a fixed exercise price. They carry preferential tax treatment under the tax code: no ordinary income tax at exercise and potential long-term capital gains treatment on the full spread, provided specific holding-period rules are met.
Generally, nothing is taxed at grant or vesting. At exercise, there's no regular income tax, but the spread between your strike price and the market value is an adjustment for Alternative Minimum Tax purposes. At sale, the treatment depends on holding periods: a qualifying disposition produces long-term capital gains on the entire gain; a disqualifying disposition produces ordinary income on some or all of the spread.
They can. The bargain element at exercise is added to your AMT income, and a large enough exercise can push your tentative minimum tax above your regular tax, creating an AMT liability. Smaller exercises may fit under your AMT break-even and trigger no additional tax—which is why sizing and modeling matter.
When the exercise fits your financial plan: you can afford the cost and projected AMT, the resulting concentration is within your risk tolerance, and the timing works for your tax year and any trading restrictions. For many employees the best answer is gradually, in sized annual tranches, rather than all at once.
That window has passed for SpaceX—the company went public in June 2026—but the framework remains instructive: pre-IPO exercise starts holding periods early and may capture a smaller spread, at the cost of AMT without liquidity and full exposure to post-IPO price declines. Employees still holding unexercised ISOs now face the (simpler) post-IPO version of the decision.
They remain options—nothing converts automatically. Vesting, expiration, and exercise mechanics continue unchanged. What changes is the environment: a transparent market price, real liquidity for exercised shares, same-day exercise-and-sell capability, and, for a period, lockups and trading windows that govern when selling is actually permitted.
For qualifying disposition treatment: at least two years from the grant date and at least one year from the exercise date. Both tests must be satisfied. Selling earlier is a disqualifying disposition with less favorable—though sometimes strategically preferable—tax treatment.
Your AMT is based on the spread at exercise, not the later price—so you can owe substantial tax on value that no longer exists. Selling within the same calendar year as the exercise generally eliminates the ISO AMT adjustment (as a disqualifying disposition), which is the main defensive move if the stock declines sharply after an exercise. AMT paid may also be partially recoverable in later years through the Minimum Tax Credit.
Mechanically yes, now that SpaceX is public—subject to lockup provisions, trading windows, and company policy. Tax-wise, an immediate sale is a disqualifying disposition: the spread is taxed as ordinary income, but the same-year sale generally avoids the AMT adjustment. Same-day exercise-and-sell is the standard tool for converting options to diversified assets without fronting cash.
Any sale of ISO shares before meeting both holding periods (two years from grant, one year from exercise). The bargain element—or the actual gain, if smaller and sold in the same year—is taxed as ordinary income rather than capital gains. It sounds like a failure; in risk-management terms, it's often the right call.
Unvested options are typically forfeited. Vested options usually must be exercised within a post-termination window—commonly 90 days—or they expire. Additionally, ISOs exercised more than three months after employment ends generally lose ISO status and are treated as NSOs. Check your grant agreements before making any employment decision with significant unexercised options outstanding.
Typically ten years from the grant date, subject to earlier expiration if you leave the company. Your specific expiration dates are in your grant agreements and equity portal—verify each grant, because they differ.
SpaceX ISOs can be one of the most valuable components of an employee's compensation—and one of the most complex. The decision to exercise should be based on more than the current stock price or a desire to minimize taxes. As the stock's post-IPO volatility has demonstrated, the spread you're taxed on and the value you ultimately keep can be very different numbers.
A successful strategy weighs your exercise cost, potential AMT liability, liquidity, concentration risk, tax situation, and broader financial goals—and it's built before you exercise, not assembled afterward from whatever happened. At Axon Capital Management, we help SpaceX employees evaluate these decisions and build strategies designed to maximize the value of their equity while managing the risks that come with having a significant portion of wealth tied to a single company.
To learn more, fill out the form below or schedule a wealth planning consultation.
Article written by Brady Lochte, founder of Axon Capital Management and a fee-only fiduciary financial advisor. Brady is committed to providing clear, transparent financial guidance that helps people navigate retirement, investing, and long-term planning with confidence.
This article is for informational and educational purposes only and does not constitute investment, tax, or legal advice. Tax rules, rates, exemption amounts, and thresholds change; verify current figures with a qualified tax professional. Hypothetical examples are simplified illustrations, do not reflect any actual client, and are not predictions of future results. Consult your advisor and CPA regarding your individual circumstances before exercising options or selling shares.
Please submit the form with any questions or comments and I'll be in touch shortly.
If you'd rather not wait, you can also book a time directly on my calendar using the link below:
Schedule a call
